Universal reference book for medicines
Product name: GAVISCON FORTE (GAVISCON FORTE)

Active substance: potassium bicarbonate, sodium alginate

Type: Antacid preparation

Manufacturer: RECKITT BENCKISER HEALTHCARE (UK) (UK)
Composition, form of production and packaging
?
Suspension for oral administration (mint) is viscous, from almost white to light brown in color, with a mint smell.
10 ml

sodium alginate 1000 mg

potassium hydrogen carbonate 200 mg

Excipients: calcium carbonate - 200 mg, carbomer - 40 mg, methylparahydroxybenzoate - 40 mg, propylparahydroxybenzoate - 6 mg, sodium hydroxide - 14.44 mg, sodium saccharinate - 10 mg, flavoring mint - 6 mg, purified water - up to 10 ml.

10 ml - packets multilayered (4) - packs cardboard.

10 ml - packets multilayered (8) - packs cardboard.

10 ml - packets multilayered (12) - packs cardboard.

10 ml - packets multilayered (16) - packs cardboard.

10 ml - packets multilayered (20) - packs cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2016.

PHARMACHOLOGIC EFFECT

Antacid preparation.
After ingestion, the drug quickly interacts with the acid content of the stomach. In this case, the alginate gel is formed, which prevents the occurrence of gastroesophageal reflux. With regurgitation, the gel enters the esophagus, where it reduces irritation of the mucous membrane.
PHARMACOKINETICS

The mechanism of action of the drug Gaviscon ® forte does not depend on absorption in the systemic bloodstream.

INDICATIONS

- symptomatic treatment of dyspepsia associated with high acidity of gastric juice and gastroesophageal reflux (heartburn, acidic eructation, a feeling of heaviness in the stomach after eating), incl.
during pregnancy.
DOSING MODE

The drug is taken orally.

Adults and children over 12 years of age are prescribed 5-10 ml of the suspension after meals and at bedtime.
The maximum daily dose is 40 ml.
For elderly patients, dose adjustment is not required.

When using bags before opening, they should be kneaded by stirring the contents.

SIDE EFFECT

Perhaps: allergic reactions - urticaria, bronchospasm, anaphylactic reactions.

CONTRAINDICATIONS

- children's age till 12 years;

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

It is possible to use Gaviscon ® forte during pregnancy and lactation (breastfeeding).

APPLICATION FOR FUNCTIONS OF THE LIVER

With caution, prescribe the drug for violations of kidney function, nephrocalcinosis and recurrent formation of kidney stones containing calcium.

APPLICATION FOR CHILDREN

Contraindicated use of the drug in childhood to 12 years.

APPLICATION IN ELDERLY PATIENTS

For elderly patients, dose adjustment is not required.

SPECIAL INSTRUCTIONS

10 ml of the suspension contains 106 mg (4.6 mmol) of sodium and 78 mg (2 mmol) of potassium.
This should be taken into account when it is necessary to maintain a diet with a limited salt content (with congestive heart failure, renal dysfunction) or with the simultaneous use of drugs that can cause the development of hyperkalemia.
It should be noted that 10 ml of the suspension contains 200 mg (2 mmol) of calcium carbonate.
Therefore, it is necessary to prescribe with caution the drug for hypercalcemia, nephrocalcinosis and recurrent formation of kidney stones containing calcium.
If there is no improvement within 7 days, the patient should consult a doctor.

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the ability to drive vehicles and mechanisms, as well as to engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

OVERDOSE

Symptoms: bloating.

Treatment: symptomatic therapy.

DRUG INTERACTION

The composition of the drug is calcium carbonate, which shows antacid activity, so between taking the drug Gaviscon ® forte and other drugs should be at least 2 hours, especially when used with blockers of histamine H 2 -receptors, antibiotics from the tetracycline group, digoxin, fluoroquinolones, iron salts, ketoconazole, neuroleptics, thyroxine, penicillamine, beta-adrenoblockers, GCS, chloroquine, diphosphates.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of reach of children at a temperature of 15 ° to 30 ° C.
Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!